Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. [PDF]
Wang TY, Zhang L, Wang HY, Jiang FF.
europepmc +1 more source
Polypharmacy and Drug-Drug Interaction Architecture in Hospitalized Cardiovascular Patients: Insights from Real-World Analysis. [PDF]
Radu AF +9 more
europepmc +1 more source
SPIRONOLACTONE INDUCED BILATERAL GYNECOMASTIA: A STAR PATIENT CASE REPORT
Dr Saba Riaz Dr. Sadaf ul Hira
openalex +1 more source
4363Do acetazolamide and spironolactone increase natriuresis in congestive heart failure? [PDF]
Frederik H. Verbrugge +8 more
openalex +1 more source
Changes in frailty based on minimally important difference and the impact of spironolactone on frailty in heart failure with preserved ejection fraction: insights from the TOPCAT trial. [PDF]
Tang Y +13 more
europepmc +1 more source
Anti-angiogenic effect of Spironolactone on a model of corneal neovascularization
Clémence Bonnet +6 more
openalex +1 more source
Efficacy and safety of colchicine and spironolactone after myocardial infarction: the CLEAR-SYNERGY trial in perspective [PDF]
Jean‐Claude Tardif, Simon Kouz
openalex +1 more source
Malignant hypertension and pseudohyperaldosteronism associated with rifampicin therapy. [PDF]
Szedleski A +4 more
europepmc +1 more source

